Cargando…

Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease

AIMS: Herein, we report safety outcomes for varenicline solution nasal spray (VNS) within the context of clinical trial discontinuation, contrasting those with discontinuation outcomes from topical cyclosporine and lifitegrast clinical trials. MATERIALS & METHODS: 1061 subjects were randomized a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauswirth, Scott G, Kabat, Alan G, Hemphill, Mandy, Somaiya, Karan, Hendrix, Laura H, Gibson, Andrea A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Becaris Publishing Ltd 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402908/ https://www.ncbi.nlm.nih.gov/pubmed/37096956 http://dx.doi.org/10.57264/cer-2022-0215

Ejemplares similares

Does Menopausal Status Affect Dry Eye Disease Treatment Outcomes with OC-01 (Varenicline Solution) Nasal Spray? A Post Hoc Analysis of ONSET-1 and ONSET-2 Clinical Trials
por: Nijm, Lisa M., et al.
Publicado: (2022)

Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?
por: Sheppard, John D., et al.
Publicado: (2023)

Varenicline Solution Nasal Spray: A Review in Dry Eye Disease
por: Frampton, James E.
Publicado: (2022)

OC-01 (Varenicline Solution) Nasal Spray Demonstrates Consistency of Effect Regardless of Age, Race, Ethnicity, and Artificial Tear Use
por: Epitropoulos, Alice T, et al.
Publicado: (2022)

Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease
por: White, Darrell E, et al.
Publicado: (2023)

OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2
por: Schallhorn, Julie M, et al.
Publicado: (2023)

The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis
por: Bashrahil, Bader, et al.
Publicado: (2023)

A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease
por: Dieckmann, Gabriela M., et al.
Publicado: (2022)

ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease
por: Wirta, David, et al.
Publicado: (2022)

Semi-PBPK Modeling and Simulation to Evaluate the Local and Systemic Pharmacokinetics of OC-01(Varenicline) Nasal Spray
por: Wu, Xiaofei, et al.
Publicado: (2022)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray
por: Werkhäuser, Nina, et al.
Publicado: (2014)

Spray Freeze Dried Lyospheres(®) for Nasal Administration of Insulin
por: Serim, Tuğrul Mert, et al.
Publicado: (2021)

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014)

Addressing varenicline adherence through repackaging in a dose administration aid
por: Drovandi, Aaron D, et al.
Publicado: (2017)

The association between self-reported varenicline adherence and varenicline blood levels in a sample of cancer patients receiving treatment for tobacco dependence
por: Crawford, Grace, et al.
Publicado: (2018)

Nano-Spray-Dried Levocetirizine Dihydrochloride with Mucoadhesive Carriers and Cyclodextrins for Nasal Administration
por: Mirankó, Mirella, et al.
Publicado: (2023)

Development of Vinpocetine-Loaded Nasal Polymeric Micelles via Nano-Spray-Drying
por: Sipos, Bence, et al.
Publicado: (2023)

Adherence to Varenicline and Associated Smoking Cessation in a Community-Based Patient Setting
por: Liberman, Joshua N., et al.
Publicado: (2013)

Atmospheric Spray Freeze Drying of Sugar Solution With Phage D29
por: Ly, Alvin, et al.
Publicado: (2019)

Comparison of Electrostatic Spray Drying, Spray Drying, and Freeze Drying for Lacticaseibacillus rhamnosus GG Dehydration
por: Jayaprakash, Preethi, et al.
Publicado: (2023)

Spray drying handbook
por: Masters, Keith
Publicado: (1988)

Unannounced telephone pill counts for assessing varenicline adherence in a pilot clinical trial
por: Thompson, Nia, et al.
Publicado: (2011)

Preparation and characterization of microparticles of piroxicam by spray drying and spray chilling methods
por: Dixit, M., et al.
Publicado: (2010)

On the Use and the Abuse of Nasal Sprays
por: Roy, Dunbar
Publicado: (1901)

Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis
por: Salapatek, Anne M., et al.
Publicado: (2021)

Varenicline in the treatment of tobacco dependence
por: Fagerström, Karl, et al.
Publicado: (2008)

Smoking cessation therapy with varenicline
por: Mohanasundaram, Uma M, et al.
Publicado: (2008)

Prevalence and incidence of dry eye in the USA: a systematic review protocol
por: McCann, Paul, et al.
Publicado: (2021)

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline
por: Tonstad, Serena, et al.
Publicado: (2016)

Cocreation of a conversational agent to help patients adhere to their varenicline treatment: A study protocol
por: Minian, Nadia, et al.
Publicado: (2023)

Formulation Development, Process Optimization, and In Vitro Characterization of Spray-Dried Lansoprazole Enteric Microparticles
por: Vora, Chintan, et al.
Publicado: (2016)

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution
por: Ishikawa, Sho, et al.
Publicado: (2023)

A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management
por: Howarth, Peter H.
Publicado: (1995)

Mechanism of Insoluble Aggregate Formation in a Reconstituted Solution of Spray-Dried Protein Powder
por: Tao, Yeqing, et al.
Publicado: (2023)

Virucidal gargling and virucidal nasal spray
por: Kramer, Axel, et al.
Publicado: (2021)

Nasal Sprays: What Apparatus to Use
por: Brown, George
Publicado: (1894)

Treatment Trends in Dry Eye Disease and Factors Associated with Ophthalmic Follow-up Discontinuation in Japan
por: Uchino, Miki, et al.
Publicado: (2019)

Solvent-Assisted Secondary Drying of Spray-Dried Polymers
por: Shepard, Kimberly B., et al.
Publicado: (2020)

Smoking cessation in Asians: focus on varenicline
por: Xiao, Dan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ptqesq4aa6sjsd882i0kclkgdt